Literature DB >> 20118713

Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.

Jun Nakayama1, Kazuo Miyasaka, Tokuhiko Omatsu, Yuuya Onodera, Satoshi Terae, Yoshihiro Matsuno, Yasushi Cho, Yasuhiro Hida, Kichizo Kaga, Hiroki Shirato.   

Abstract

OBJECTIVE: To evaluate diffusion-weighted magnetic resonance (DW-MR) imaging for detection of metastases in lymph nodes by using quantitative analysis.
METHODS: Seventy patients with non-small cell lung cancer were examined with DW and short inversion time inversion recovery (STIR) turbo-spin-echo MR imaging. Apparent diffusion coefficient of each lung cancer and lymph node was calculated from DW-MR images. Difference of the apparent diffusion coefficient in a lung cancer and a lymph node was calculated (D1). From STIR turbo-spin-echo MR images, ratios of signal intensity in a lymph node to that in a 0.9% saline phantom was calculated (lymph node-saline ratio [LSR1]). For quantitative analysis, the threshold value for a positive test was determined on a per node basis and tested for ability to enable a correct diagnosis on a per patient basis. Results of quantitative analyses of DW- and STIR-MR images were compared on a per patient basis with McNemar testing.
RESULTS: Mean D1 in the lymph node group with metastases was lower than that in the group without metastases (P < 0.001). When an D1 of 0.24 x 10(-3) mm2/s was used as the positive test threshold, sensitivity, specificity, and accuracy were 69.2%, 100%, and 94.0%, respectively, on a per patient basis. There was no significant difference (P > 0.05) between quantitative analyses of DW-MR images and STIR-MR images.
CONCLUSIONS: Quantitative analysis of DW-MR images enables differentiation of lymph nodes with metastasis from those without.

Entities:  

Mesh:

Year:  2010        PMID: 20118713     DOI: 10.1097/RCT.0b013e3181a9cc07

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  21 in total

1.  Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.

Authors:  Gregor Sommer; Mark Wiese; Leopold Winter; Claudia Lenz; Markus Klarhöfer; Flavio Forrer; Didier Lardinois; Jens Bremerich
Journal:  Eur Radiol       Date:  2012-07-09       Impact factor: 5.315

2.  MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.

Authors:  Ji-Qun Geng; Xiao-Chen Wang; Long-Fei Li; Jun Zhao; Song Wu; Gui-Ping Yu; Kou-Jun Zhu
Journal:  Tumour Biol       Date:  2015-09-10

3.  N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: initial experience.

Authors:  A A Kohan; J A Kolthammer; J L Vercher-Conejero; C Rubbert; S Partovi; R Jones; K A Herrmann; P Faulhaber
Journal:  Eur Radiol       Date:  2013-06-14       Impact factor: 5.315

4.  Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging.

Authors:  Sevtap Gümüştaş; Nagihan Inan; Hasan Tahsin Sarisoy; Yonca Anik; Arzu Arslan; Ercüment Ciftçi; Gür Akansel; Ali Demirci
Journal:  Eur Radiol       Date:  2011-06-23       Impact factor: 5.315

Review 5.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

6.  A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer.

Authors:  Yoo Na Kim; Chin A Yi; Kyung Soo Lee; O Jung Kwon; Ho Yun Lee; Byung-Tae Kim; Joon Young Choi; Seon Woo Kim; Man Pyo Chung; Joungho Han; Tae Sung Kim; Myung Jin Chung; Young Mog Shim
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

Review 7.  [New procedures. Comprehensive staging of lung cancer by MRI].

Authors:  C Hintze; J Dinkel; J Biederer; C P Heussel; M Puderbach
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

8.  Diffusion-weighted imaging with background body signal suppression (DWIBS) distinguishes benign lesions from malignant pulmonary solitary lesions.

Authors:  Chunli Zhao; Dong Deng; Wei Ye; Liling Long; Yumin Lu; Youyong Wei
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

9.  Diffusion magnetic resonance imaging with gadofosveset trisodium as a negative contrast agent for lymph node metastases assessment.

Authors:  Tomohiro Yamashita; Taro Takahara; Thomas C Kwee; Shuichi Kawada; Tomohiko Horie; Chie Inomoto; Kazunobu Hashida; Hiroshi Yamamuro; Kazunori Myojin; Peter R Luijten; Yutaka Imai
Journal:  Jpn J Radiol       Date:  2011-01-26       Impact factor: 2.374

Review 10.  Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer.

Authors:  Shaheen Islam; Ronald C Walker
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.